Thyroseq v3 Genomic Classifier (GC) Testing

The Department of Veterans Affairs (VA) intends to award a sole source Five (5) year Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc. (CBLPath) for Thyroseq v3 Genomic Classifier (GC) testing. The testing service will be provided for the Department of Veterans Affairs throughout VISN1 VA Medical Centers. Although this is a sole source notice, other responsible firms that believe they can meet the requirement can submit written notification and capability statements prior to the response due date. The responses should include company information, point of contact details, business size, and relevant experience. • The NAICS code for this acquisition is 621511. • The size standard is $41.5 million. • Responses are due by 07/17/2026 at 6:00 AM Eastern Standard Time. • The contract will be a BPA for a five-year period. • The VISN1 Network Consolidated Laboratory (NCL) requires Thyroseq v3 Genomic Classifier (GC) testing.